Positive results from Aestus' ATx08-001 Phase II study on post-herpetic neuralgia

Aestus Therapeutics, Inc. (Aestus) today reported positive results from a Phase II clinical study evaluating the efficacy of its novel neuropathic pain therapeutic, ATx08-001, in the treatment of post-herpetic neuralgia (PHN). Results in patients on ATx08-001 monotherapy met the study's primary objectives of demonstrating significant analgesia in PHN neuropathic pain sufferers while showing an excellent safety profile.

The randomized, double-blind, placebo-controlled, multi-center study of two doses of ATx08-001 over eight days of treatment, was designed to test the ability of ATx08-001 to relieve PHN, the persistent pain which often occurs after an outbreak of shingles. In the study, patients receiving only ATx08-001 showed a statistically significant reduction in the Mean Pain Intensity Score (MPIS) after one week of treatment, at both doses of ATx08-001 tested (2.5 and 7.5 mg bid). This analgesic effect compares very favorably with published results for the standard of care medication.

"Aestus is pleased with the results showing analgesic effect of ATx08-001," stated Tage Honore, PhD, DSc, President and CEO of Aestus. "This is truly a remarkable result with ATx08-001, as the current standard of care medication would need five times as many patients to achieve a comparable result in a clinical trial. In addition, it provides very strong proof for our core technology, the Aestus engine, which produced potential therapeutics with proof-of-efficacy in patients for one-tenth of the cost in one- fifth of the time as compared to the classical pharma R&D process."

The trial had no patients drop out of the study due to adverse events, or due to the need for rescue medications. This supports the strong safety profile of ATx08-001, which has been the subject of clinical trials in over 800 patients to date.

Source:

 Aestus Therapeutics, Inc.

Comments

  1. Nateson Janarthanan Nateson Janarthanan India says:

    I am suffering this PHN for the past Six Years immediately after staying in US for about Six months. I tried every possible treatment with negative results. I am 79 years old man.
    Is there a chance of getting the medicine in India. Kindly respond.
    Sincerely,
    N.Janarthanan,
    # 6, Taylors Estate First Street,
    Flay # 6, RAM Apartments,
    Kodambakkam, Chennai 600024 ( South India ).  

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Triptans better at relieving migraine pain than recently marketed and more expensive drugs